Wockhardt third-quarter profit falls 29 percent

MUMBAI Mon Feb 10, 2014 9:37am IST

Pharmaceutical tablets and capsules in foil strips are arranged on a table in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic/Files

Pharmaceutical tablets and capsules in foil strips are arranged on a table in this picture illustration taken in Ljubljana September 18, 2013.

Credit: Reuters/Srdjan Zivulovic/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - Wockhardt Ltd(WCKH.NS) reported a 29 percent drop in quarterly net profit, hit by a fall in sales after the U.S. health regulator banned two of the drugmaker's plants from exporting products to the United States - its largest market.

In November, the U.S. Food and Drug Administration issued an import alert, effectively a ban, against Wockhardt's Chikalthana plant in western India. The FDA had imposed a ban on the company's Waluj plant in May.

Wockhardt's net profit in the third quarter fell to 3.04 billion rupees from 4.28 billion rupees a year earlier, the company said in a statement late on Sunday. Total sales dropped 14 percent to 12.37 billion rupees.

The company's U.S. business, which accounts for 44 percent of revenue, fell 30 percent in the quarter.

(Reporting by Sumeet Chatterjee; Editing by Supriya Kurane)

FILED UNDER:

REUTERS SHOWCASE

Oil Prices

Oil Prices

Brent climbs above $62 as Asian markets open strong  Full Article 

Tracking Gold

Tracking Gold

Gold inches up but holds below $1,200 on robust equities, dollar  Full Article 

Cyber Attacks

Cyber Attacks

China condemns cyberattacks, but does not mention North Korea  Full Article 

Connecting Markets

Connecting Markets

China stock connect scheme scorecard throws up surprises  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage